A phase I/II study of eribulin mesilate (ERI) plus irinotecan (IRI) in children with refractory or recurrent solid tumors.

被引：0
|
作者：
Casanova, Michela
Kramm, Christof
Reinhardt, Dirk
Locatelli, Franco
D'Adamo, David R.
Scott, Rachael
Jia, Yan
Aluri, Jagadeesh
Favre, Claudio
Bautista, Francisco
Alvaro, Raquel Hladun
Urgelles, Ana Sastre
Kontny, Udo
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] Univ Med Ctr Gottingen, Gottingen, Germany
[3] Univ Duisburg Essen, Essen, Germany
[4] Sapienza Univ Rome & Bambino Gesu, Childrens Res Hosp IRCCS, Rome, Italy
[5] Eisai Inc, Woodcliff Lake, NJ USA
[6] Eisai Ltd, European Knowledge Ctr, Hatfield, Herts, England
[7] Meyer Childrens Hosp, Florence, Italy
[8] Nino Jesus Univ Childrens Hosp, Madrid, Spain
[9] Univ Hosp Vall dHebron, Barcelona, Spain
[10] La Paz Univ Hosp, Madrid, Spain
[11] Rhein Westfal TH Aachen, Aachen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10535
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase I study of talazoparib and irinotecan in children and young adults with recurrent/refractory solid tumors.
    Federico, Sara Michele
    Stewart, Elizabeth
    Coleman, Jamie L.
    Bishop, Michael William
    Santana, Victor M.
    Lam, Catherine
    Hawkins, Dana
    Wu, Jianrong
    Mao, Shenghua
    Goshorn, David Ross
    Papp, Alberto S.
    Dyer, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Phase I Study of Bevacizumab Plus Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors
    Okada, Keiko
    Yamasaki, Kai
    Tanaka, Chika
    Fujisaki, Hiroyuki
    Osugi, Yuko
    Hara, Junichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (11) : 1073 - 1079
  • [3] Phase I study of regorafenib in combination with vincristine and irinotecan in pediatric patients with recurrent or refractory solid tumors.
    Casanova, Michela
    Bautista, Francisco
    Hewson, Quentin Campbell
    Makin, Guy
    Marshall, Lynley V.
    Verschuur, Arnauld
    Canete, Adela
    Corradini, Nadege
    Ploeger, Bart
    Mueller, Udo
    Zebger-Gong, Hong
    Chung, John Woojune
    Geoerger, Birgit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] A phase I/II study of lenvatinib (LEN) plus everolimus (EVE) in recurrent and refractory pediatric solid tumors, including CNS tumors.
    Dela Cruz, Filemon S.
    Fox, Elizabeth
    Muscal, Jodi Ann
    Kirov, Ivan
    Geller, James I.
    DuBois, Steven G.
    Kim, AeRang
    Croop, James
    Laetsch, Theodore Willis
    Minard, Charles G.
    Liu, Xiaowei
    Weigel, Brenda
    Okpara, Chinyere E.
    Huang, Jie
    Dutta, Lea
    Aluri, Jagadeesh
    Bender, Julia Lynne Glade
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] A phase I study of gefitinib and irinotecan (IRN) in pediatric patients with refractory solid tumors.
    Furman, WL
    Daw, NC
    Crews, KR
    Stewart, CF
    McCarville, B
    Santana, VM
    Hawkins, D
    Rodriguez-Galindo, C
    Navid, F
    Houghton, PJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 804S - 804S
  • [6] A phase I study of irinotecan as a 3-week schedule in children with refractory or recurrent solid tumors
    Vassal, G
    Doz, F
    Frappaz, D
    Imadalou, K
    Sicard, E
    Santos, A
    O'Quigley, J
    Germa, C
    Risse, ML
    Mignard, D
    Pein, F
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (20) : 3844 - 3852
  • [7] A phase I study of temsirolimus plus erlotinib in patients with refractory solid tumors.
    Wang-Gillam, Andrea
    Tan, Benjamin R.
    Waqar, Saiama Naheed
    Suresh, Rama
    Morgensztern, Daniel
    Van Tine, Brian Andrew
    Nieman, Rebecca
    Govindan, Ramaswamy
    Lockhart, Albert C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] A phase I study of sirolimus in combination with metronomic therapy in children with recurrent and refractory solid/CNS tumors.
    Qayed, Muna
    Cash, Thomas
    Tighiouart, Mourad
    MacDonald, Tobey
    Goldsmith, Kelly C.
    Kean, Leslie S.
    Church, Patty
    Katzenstein, Howard M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumors
    Carlos Rodriguez-Galindo
    Kristine R. Crews
    Clinton F. Stewart
    Wayne Furman
    J. Carl Panetta
    Najat C. Daw
    Alvida Cain
    Ming Tan
    Peter H. Houghton
    Victor M. Santana
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 15 - 24
  • [10] Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumors
    Rodriguez-Galindo, C
    Crews, KR
    Stewart, CF
    Furman, W
    Panetta, JC
    Daw, NC
    Cain, A
    Tan, M
    Houghton, PH
    Santana, VM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (01) : 15 - 24
12345